NexImmune Inc.
(NEXI)
undefined
undefined%
At close: undefined
3.45
2220.11%
After-hours Jul 11, 2024, 07:59 PM EDT
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 1.02M | 1.50M | 870.28K | 618.99K | 436.37K | 204.65K |
| Gross Profit | -1.02M | -1.50M | -870.28K | -618.99K | -436.37K | -204.65K |
| Operating Income | -29.19M | -63.08M | -53.26M | -27.85M | -20.89M | -13.24M |
| Interest Income | 698.39M | 664.37K | 52.51K | 20.84K | 246.78K | 272.44K |
| Pretax Income | -32.34M | -62.51M | -50.90M | -29.87M | -20.55M | -12.83M |
| Net Income | -32.34M | 514.18M | -51.75M | -31.64M | -20.30M | -12.83M |
| Selling & General & Admin | 9.91M | 15.93M | 15.80M | 10.01M | 5.71M | 5.24M |
| Research & Development | 18.26M | 47.15M | 37.46M | 17.84M | 15.17M | 8.00M |
| Other Expenses | n/a | -87.68K | -61.41K | 89.78K | 92.28K | 136.79K |
| Operating Expenses | 28.17M | 63.08M | 53.26M | 27.85M | 20.89M | 13.24M |
| Interest Expense | n/a | n/a | 905.33K | 1.68M | n/a | n/a |
| Selling & Marketing Expenses | -12.99B | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 29.19M | 63.08M | 53.26M | 27.85M | 20.89M | 13.24M |
| Income Tax | -2 | -576.69M | 843.92K | 1.77M | -246.78K | 409.22K |
| Shares Outstanding (Basic) | 1.05M | 962.36K | 913.16K | 910.31K | 900.86K | 900.86K |
| Shares Outstanding (Diluted) | 1.05M | 962.36K | 913.16K | 910.31K | 900.86K | 900.86K |
| EPS (Basic) | -30.82 | 534.29 | -56.67 | -34.76 | -22.53 | -14.25 |
| EPS (Diluted) | -30.82 | 534.29 | -56.67 | -34.76 | -22.53 | -14.25 |
| EBITDA | -28.17M | -61.59M | -52.39M | -27.12M | -20.45M | -13.04M |
| Depreciation & Amortization | 1.02M | 1.50M | 870.28K | 618.99K | 436.37K | 204.65K |